The UK's £1.6bn national AI strategy targets healthcare breakthroughs from cancer detection to drug discovery. The AI healthcare market is forecast to reach US$696bn by 2034, a 38.5% CAGR.
Novartis has announced three separate partnership deals worth over $5 billion combined with Antares Therapeutics, Orionis Biosciences, and Unnatural Products. The agreements target undruggable cancers, molecular glue drugs, and cardiovascular therapies respectively using each partner's proprietary platforms.
The US pharmaceutical drug delivery market is projected to rise from USD 0.94 billion in 2026 to USD 1.24 billion by 2031 at a 5.8% CAGR. Injectables, oncology applications, and home care settings are expected to post the fastest growth.
Europe's infusion pump market is projected to reach USD 7.09 billion by 2031 at a 6.8% CAGR. Growth is driven by connected systems, tighter safety standards, homecare use, and diabetes demand.
The healthcare 3D printing market is projected to reach $14.6 billion by 2033, while the bioinks market is anticipated to reach USD 683.6 million. Growth is tied to personalised medical solutions, tissue engineering, drug discovery, and advances in biomaterials.
CRISPR Therapeutics reported a $581.6 million net loss in 2025 with revenue of just $3.5 million, while continuing to advance its gene-editing pipeline including the approved CASGEVY therapy and next-generation CAR T cell programs. The company maintains strategic partnerships and expects current funds to support operations for at least 24 months.
Analysis of 585 clinical trials reveals region is the primary driver of risk variation, with North America showing 29% higher screen failure rates. Heart failure trials show severe underrepresentation, with only 14.5% of participants from outside Europe and North America despite Asia having 50% of global heart failure cases. Central monitoring methods and representativeness indices are proposed to address these disparities.
Origin Genomics launches to pursue germline gene editing research despite US prohibitions, while Thermo Fisher completes its $8.88 billion acquisition of Clario Holdings. Lucid Diagnostics reports Q4 revenue growth, and multiple partnerships form across the diagnostics and synthetic biology sectors.
Three recent studies reveal connections between gut microbiome composition and health outcomes, identifying specific bacterial groups associated with recovery and disease, plus genetic variants that shape microbial communities.
YolTech Therapeutics received FDA approval for its IND application for YOLT-202, an in vivo gene-editing therapy for Alpha-1 Antitrypsin Deficiency. Interim data from an ongoing trial showed rapid increases in AAT levels to normal range with favorable safety.
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07775976 |
Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways |
ENROLLING_BY_INVITATION | |
| NCT07770737 |
Cardioprotective Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Korean Patients With Type 2 Diabetes |
NOT_YET_RECRUITING | |
| NCT07763340 |
Photon-Counting Cardiac CT in Post-PCI Patients |
RECRUITING | |
| NCT07746310 |
Dietary Nitrate and Nitrite Intake and Phosphate Biomarkers and Risk of Chronic Diseases |
COMPLETED | |
| NCT07741955 |
Empowering Veterans in Research Effectively Using Virtual Engagement Tools |
NOT_YET_RECRUITING | NA |
| NCT07727135 |
Rapid or Ultra-rapid Diagnosis of Myocardial Infarction Using High-Sensitivity Cardiac Troponin on Hospital Presentation |
NOT_YET_RECRUITING | NA |
| NCT07721649 |
Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP) |
NOT_YET_RECRUITING | NA |
| NCT07721584 |
HeartMate App-Based Remote Monitoring for Cardiovascular Risk Factor Management |
NOT_YET_RECRUITING | NA |
| NCT07717723 |
Supporting Mental Health and Reducing Care Stress in Caregivers of Persons With Cardiovascular Disease |
RECRUITING | NA |
| NCT07693712 |
Senescence in Myocardial Infarction |
TERMINATED |
